Bristol-Myers Squibb Company
BMYNYSEHealthcare● Active
$55.57
$-1.70(-2.97%)
Market Cap$113.5B
P/E Ratio—
52W High$62.89
52W Low$42.52
Bristol-Myers Squibb Company (BMY) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BMY · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $7.05B | ($8.93B) | $8.04B | $6.34B | $7.01B |
| Depreciation & Amort. | $4.01B | $9.60B | $9.76B | $10.28B | $10.69B |
| Stock-Based Comp. | $0.55B | $0.51B | $0.52B | $0.46B | $0.58B |
| Change in Working Capital | ($0.46B) | $0.81B | ($1.91B) | ($2.23B) | ($1.26B) |
| Net Cash from Operations | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B |
| Investing Activities | |||||
| Capital Expenditure | ($1.31B) | ($1.25B) | ($1.21B) | ($1.12B) | ($0.97B) |
| Purchases of Investments | ($2.00B) | ($0.77B) | ($1.77B) | ($3.59B) | ($5.48B) |
| Sales of Investments | $2.05B | $1.39B | $0.95B | $6.63B | $6.78B |
| Net Cash from Investing | ($4.13B) | ($21.35B) | ($2.29B) | ($1.06B) | ($0.54B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($5.16B) | ($8.00B) | ($6.29B) |
| Dividends Paid | ($5.04B) | ($4.86B) | ($4.74B) | ($4.63B) | ($4.40B) |
| Debt Issued / Repaid | ($5.17B) | $10.10B | $0.46B | ($5.31B) | ($6.18B) |
| Net Cash from Financing | ($10.35B) | $5.13B | ($9.42B) | ($16.96B) | ($16.22B) |
| Free Cash Flow | |||||
| Free Cash Flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B |
| FCF Margin %(computed) | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Bristol-Myers Squibb Company data
About Bristol-Myers Squibb Company (BMY) Cash Flow Statement
Bristol-Myers Squibb Company generated operating cash flow of $14.16B and free cash flow of $12.85B for 2025 — a FCF margin of 26.65%. Capital expenditure was ($1.31B).
Frequently asked questions
BMY · 4 questionsBristol-Myers Squibb Company generated free cash flow of $12.85B for 2025, down 7.9% year-over-year.
BMY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10